Search

Sartorius Stedim Biotech.

Closed

SectorFinance

189.3 -0.84

Overview

Share price change

24h

Current

Min

186.1

Max

190.9

Key metrics

By Trading Economics

Income

4.9M

93M

Sales

4.2M

766M

P/E

Sector Avg

61.96

21.734

EPS

1.25

Dividend yield

0.36

Profit margin

12.146

Employees

10,477

EBITDA

9.2M

240M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+26.05% upside

Dividends

By Acuity

Dividend yield

Sector Avg

0.36%

4.42%

Next Earnings

22 Oct 2026

Market Stats

By TradingEconomics

Market Cap

611M

18B

Previous open

190.14

Previous close

189.3

News Sentiment

By Acuity

34%

66%

82 / 436 Finance

Sartorius Stedim Biotech. Chart

Past performance is not a reliable indicator of future results.

Related News

8 Sept 2026, 23:56 UTC

News

Korn Ferry's Board declared a quarterly cash dividend of $0.55 per share, payable October 15. Shares traded roughly flat in after-market hours.

8 Sept 2026, 23:56 UTC

Social Media
News

Chevron Corp shares are higher in after-market hours following a report on declining OECD strategic petroleum reserves, which may impact oil prices and benefit the company.

8 Sept 2026, 23:46 UTC

News
Social Media

Warner Bros Discovery Inc. shares are higher in after-market hours following Paramount Skydance's court filings on merger progress, indicating potential $1.88 billion impact.

8 Sept 2026, 23:41 UTC

News

BJ's Restaurants shares are trading lower in after-market hours following a presentation at the Barclays Consumer Staples Conference focused on a strategic reset.

8 Sept 2026, 23:41 UTC

News

Boston Beer Company appointed Allison Stransky as Chief Marketing Officer, effective October 12, 2026. Shares are trading higher in after-market hours.

8 Sept 2026, 23:41 UTC

News

Goldman Sachs has agreed to acquire NEOS Investments for $2.25 billion, with shares trading lower in after-market hours following the announcement.

8 Sept 2026, 23:36 UTC

News
Correlated Moves

Piper Sandler initiated coverage of Quanta Services with an Overweight rating. Shares rose in after-market trading, closing at $624.41.

8 Sept 2026, 23:36 UTC

News

Shutterstock Inc appointed three new board members to enhance governance. Shares are trading higher after the announcement of Timothy Adams, Matthew Salzberg, and Michael Thompson.

8 Sept 2026, 23:36 UTC

News

Air Products and Chemicals reported stronger third-quarter profitability, boosting full-year guidance. Shares traded higher in after-market hours following the results.

8 Sept 2026, 23:31 UTC

News

NetApp shares are trading higher in after-market hours following CEO George Kurian's discussion at the Goldman Sachs Communacopia + Technology Conference.

8 Sept 2026, 23:31 UTC

News

Estee Lauder Companies announced expanded leadership roles for Brian Franz and Amber English. Shares traded lower during after-market hours following the news.

8 Sept 2026, 23:21 UTC

News

Prestige Consumer Healthcare Inc shares are lower in after-market trading amid geopolitical tensions and inflation concerns affecting market sentiment across sectors.

8 Sept 2026, 23:21 UTC

News

Target Corp shares are higher in after-market trading, supported by recent turnaround efforts despite an analyst downgrade to a hold rating.

8 Sept 2026, 23:21 UTC

News

Tapestry Inc gains in after-market trading, with a market cap of $23.69 billion. A $100 investment five years ago is now worth approximately $290.54.

8 Sept 2026, 23:16 UTC

News

Stanley Black & Decker shares are higher in after-market trading following the announcement of CEO Chris Nelson's upcoming presentation at a Morgan Stanley conference.

8 Sept 2026, 23:11 UTC

News

Travel + Leisure Co shares are higher in after-market hours following the announcement of CFO Erik Hoag's participation in a Goldman Sachs conference on September 14, 2026.

8 Sept 2026, 23:06 UTC

News

Lowe's CEO Marvin R. Ellison will participate in a Goldman Sachs conference on September 15, 2026. Shares are higher in after-market trading.

8 Sept 2026, 23:06 UTC

Social Media
News
Correlated Moves

Citigroup plans to offer instant cross-border payments using blockchain technology for Japanese firms. Shares are higher in after-market trading following the announcement.

8 Sept 2026, 23:06 UTC

Social Media
News

General Electric shares rise in after-market hours amid interest in strategic developments, including a $11.75 billion acquisition and potential valuation boost for Precision Castparts.

8 Sept 2026, 23:06 UTC

News

Eli Lilly's Mounjaro received FDA approval to reduce heart-attack and stroke risk in adults with type 2 diabetes. Shares advanced slightly in after-market trading.

8 Sept 2026, 23:06 UTC

News

NextEra Energy Inc. shares are trading higher in after-market hours as management announces investor meetings to discuss growth expectations and the Dominion Energy merger.

8 Sept 2026, 23:06 UTC

News

Merck & Co. shares are higher after Karim Mikhail's appointment to lead the FDA's Center for Biologics Evaluation and Research, boosting the company's regulatory reputation.

8 Sept 2026, 23:06 UTC

News

General Mills has filed an antitrust lawsuit against major U.S. sugar producers for alleged price collusion, with shares trading higher in after-market hours.

8 Sept 2026, 23:06 UTC

News

VICI Properties Inc. shares are trading higher in after-market hours following the release of its 2025-2026 Corporate Responsibility Report, highlighting sustainability efforts.

8 Sept 2026, 23:06 UTC

Event
News

Roivant Sciences Ltd shares are lower in after-market hours despite positive Phase 2 trial results for mosliciguat targeting pulmonary hypertension.

8 Sept 2026, 23:01 UTC

Social Media
News

AT&T's CEO highlights growth potential and $45B shareholder return plan at Goldman Sachs conference; shares rise in after-market hours.

8 Sept 2026, 23:01 UTC

News

Ares Capital Corp priced a $750 million public offering of unsecured notes, aiming to enhance financial flexibility. Shares are trading higher in after-market hours.

8 Sept 2026, 23:01 UTC

News

Constellation Brands plans to redeem $600 million in Senior Notes due 2027, contributing to a rise in shares during after-market trading.

8 Sept 2026, 23:01 UTC

Correlated Moves
News
Event
Social Media

Braze Inc shares fell sharply in after-hours trading despite strong second-quarter results, as weaker third-quarter EPS guidance raised investor concerns.

8 Sept 2026, 23:01 UTC

Social Media
News

GameStop shares fell in after-hours trading despite reporting adjusted EPS of $0.27 and raising its fiscal year 2026 EBITDA outlook to over $650 million.

Peer Comparison

Price change

Sartorius Stedim Biotech. Forecast

Price Target

By TipRanks

26.05% upside

12 Months Forecast

Average 240 EUR  26.05%

High 260 EUR

Low 210 EUR

Based on 5 Wall Street analysts offering 12 month price targets forSartorius Stedim Biotech. - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

5 ratings

5

Buy

0

Hold

0

Sell

Sentiment

By Acuity

82 / 436 Finance

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Sartorius Stedim Biotech.

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.
help-icon Live chat